Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
about
Insights into Newer Antimicrobial Agents Against Gram-negative BacteriaTargeting Antibiotic ResistanceThe Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial RibosomeAntibiotics in the clinical pipeline at the end of 2015.In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis.Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.In Vitro and In Vivo Assessments of Cardiovascular Effects with Omadacycline.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Reversing resistance: The next generation antibacterials.Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.Effect of Food on the Bioavailability of Omadacycline in Healthy Participants.Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.Tetracycline antibiotics and resistance mechanisms.Natural product and natural product derived drugs in clinical trials.Eravacycline for the treatment of intra-abdominal infections.Tetracycline Antibiotics and Resistance.Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of 14C-Omadacycline in Rats.Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model.Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe.In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.Pharmacokinetics and Safety of Omadacycline in Subjects With Impaired Renal Function.Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens.Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program.Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline.
P2860
Q26751255-60138DF9-70A5-4319-88F4-4C89871EAD8CQ28078130-2454B569-DCAF-49D2-AAFB-2F0D43071E53Q28818623-554C25D4-5B19-49E3-8EF6-0A7DCA71FBCDQ30249262-F46A3CEE-FE76-43E9-BD09-BA28FD0088B6Q33601803-8CB690C9-2677-4BE0-891F-D55D7941AED0Q34493150-5608923E-9ECE-4A43-8651-D7E0510853B5Q34531473-F5D10526-B90F-49CA-B431-5D6D89408D69Q35482558-7EE029D3-ABF5-4F29-94C4-011D44A81080Q35669688-D33A73C7-9EA0-43E5-954A-3014A4F228FFQ37428710-5DBF836A-0D37-4C74-845C-3AA8343F028DQ37664108-FDDA196B-7955-4220-8AB4-595E0FD93566Q37835462-A46E3F4A-53D7-48B7-A3C0-EE0E4FB727F4Q38185338-86BC861D-2A7B-4B75-899A-6EFD44063E22Q38247457-3334E73D-4C60-44E8-AFDF-42D0F4F4FD75Q38253877-A6980FA7-83E3-4FB3-8A0D-29FC617762EBQ38779243-48020D8C-5C2E-4F3B-A63A-2C7018868CE1Q39118434-53943761-D8AE-4322-B116-37F9EDA28F3BQ40035130-FAC17A09-0090-43DA-A23F-D87A2F6E0BA8Q40140013-BECAC4F7-C8F9-4FB3-B41C-E0856F388047Q40323052-43992790-6BF2-4C58-8EFA-36E36B823C31Q40334499-90ECA1AF-0F73-46C1-86C8-06C96FD7FF0FQ40403783-7B1F7547-9D45-4A25-B29D-AB6E7B923143Q40526816-75016372-3B0B-47D8-9B38-968EB598695AQ47439634-2F5DD234-BA53-4B80-A021-F0C8BDEE1AD5Q49587227-F086B8E6-23AA-4AF8-AF68-CC999340798DQ49598780-A8D53ED4-0D8D-47D2-8249-58CF802939FAQ51587016-6AEEB25B-C50A-4CE4-953D-71B9C03AEFE0
P2860
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@ast
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@en
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@nl
type
label
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@ast
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@en
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@nl
prefLabel
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@ast
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@en
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
@nl
P2093
P2860
P356
P1476
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline
@en
P2093
J Donatelli
Michael P Draper
S K Tanaka
Stuart B Levy
P2860
P304
P356
10.1128/AAC.01066-13
P407
P577
2013-09-16T00:00:00Z